FIELD: chemistry.
SUBSTANCE: invention relates to a novel cyclic peptide compound of pharmaceutically acceptable salt thereof, having activity against hepatitis C virus, based on inhibiting activity against replication of the hepatitis C virus RNA replicon, a pharmaceutical composition containing said compound or pharmaceutically acceptable salt thereof, and use of the compounds or pharmaceutically acceptable salt thereof to prepare a medicinal agent with anti-HCV activity.
EFFECT: high efficiency of the compounds.
9 cl, 19 tbl, 259 ex
Title | Year | Author | Number |
---|---|---|---|
MACROHETEROCYCLIC COMPOUNDS | 2001 |
|
RU2275373C2 |
SUBSTITUTED 3-AMINOQUINUCLIDINES | 1992 |
|
RU2092486C1 |
HETEROCYCLIC COMPOUNDS MODULATING ACTIVITY OF CHEMOKINE RECEPTOR, THEIR USING AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF | 2001 |
|
RU2297413C2 |
DERIVATIVES OF TAXANE FUNCTIONED BY POSITION 14 AND METHOD FOR THEIR PREPARING | 2003 |
|
RU2320652C2 |
SULFONAMIDE PERI-SUBSTITUTED BICYCLES FOR TREATMENT OF OCCLUSIVE AFFECTION OF ARTERIES | 2005 |
|
RU2403240C2 |
MODULATORS OF ATP-BINDING TRANSPORTERS | 2010 |
|
RU2552353C2 |
SPIROPIPERIDINES, METHODS OF THEIR SYNTHESIS (VARIANTS) | 1993 |
|
RU2168512C2 |
NITROIMIDAZOOXAZINE AND NITROIMIDAZOOXAZOLE ANALOGUES AND USE THEREOF | 2010 |
|
RU2540860C2 |
MODULATORS OF ATP-BINDING CARTRIDGE TRANSPORTERS | 2005 |
|
RU2528046C2 |
METHOD OF MODULATING TRANSPORTERS OF ATP-BINDING CASSETTE | 2005 |
|
RU2525115C2 |
Authors
Dates
2011-12-20—Published
2008-04-25—Filed